Data Bridge Market Research recently conducted an in-depth market intelligence study on the End Stage Renal Disease (ESRD) Drug Market. Their newly published report employs an engaging layout, utilizing visually appealing tables, graphs, charts, and figures to present essential data.

The market research report for the End Stage Renal Disease (ESRD) Drug market is the result of several fundamental steps in market research analysis, including surveys, focus groups, personal interviews, observations, and field trials. It is instrumental in steering businesses towards success. Moreover, the report presents crucial proposals for potential projects in the ESRD drug market, assessing their feasibility. This comprehensive market report contains data crucial for dominating or establishing a foothold in the market as a newcomer. It serves as a valuable resource, offering current and future technical and financial details within the industry.

Understanding consumer trends and supply chain dynamics, this extensive End Stage Renal Disease (ESRD) Drug market report aids in devising effective strategies for sales, marketing, and promotion. In a rapidly evolving marketplace, businesses need a wide-ranging approach for successful growth, and this market report serves that purpose excellently. Included in this report is a dedicated chapter on the global ESRD Drug market and its associated companies, providing valuable insights into their financial outlooks, product portfolios, investment plans, and marketing and business strategies.

According to Data Bridge Market Research, the end stage renal disease (ESRD) drug market is projected to experience substantial growth in the forecast period from 2023 to 2030. The anticipated Compound Annual Growth Rate (CAGR) for the ESRD drug market during this period is around 13.4%. The market value, estimated at USD 98.74 billion in 2022, is expected to surge to USD 270.01 billion by 2030. Beyond fundamental market insights such as value, growth rate, segments, geographical coverage, and market players, the report curated by Data Bridge Market Research also includes expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

 

Get a Sample Research Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-end-stage-renal-disease-esrd-drug-market

According to the reports of the CDC, it is anticipated that more than 37 million people in the U.S. are suffering from CKD, however, globally, more than 500 million people are affected. An increasing number of patients suffering from kidney failure is estimated to drive the market. It has also been witnessed that people suffering from ESRD and diabetes are susceptible to COVID-19 complications compared to healthy individuals.

Key Growth Drivers:

  • Increased Incidence of Kidney Disease

The growing incidence of chronic end stage renal disease (ESRD) drug worldwide is majorly responsible for increasing market growth. According to the National Kidney Foundation records, approximately 10% of the global population is affected by chronic end-stage renal disease (ESRD) drug (CKD). According to WHO 2019, around 1.13 billion people globally have hypertension. In 2014–2016, diabetes and hypertension were majorly responsible for about 75% of kidney failure. Thus, it boosts market growth.

  • Rising Demand For Blood Tests

Out of all the major tests, the main test for the diagnosis of end stage renal disease (ESRD) drug includes a blood test that helps understand the kidneys' functionality. It measures levels of a waste product known as creatinine in the blood. Additionally, the demand for these tests is expected to increase as the occurrence of CKD is high and increasing in many parts of the world. The global incidence of end-stage renal disease (ESRD) is high and rising at a huge rate. Therefore, it creates more opportunities for the market growth.

The report outlines the involvement of key players, including:

Pfizer Inc (U.S.), AstraZeneca (U.K.), Bristol-Myers Squibb Company (U.S.), Dr. Reddy's Laboratories Ltd (India), Endo International plc (Ireland), Teva Pharmaceutical Industries Ltd (Israel), Sun Pharmaceutical Industries Ltd (India), Mylan N.V. (U.S.), Novartis AG (Switzerland), Lupin (India), Cipla Inc (India), Aurobindo Pharma (India), Fresenius SE & Co. KGaA (Germany), Sanofi (France), Takeda Pharmaceutical Company Limited (Japan), F. Hoffmann-La Roche Ltd (Switzerland), Abbott (U.S.), Kissei Pharmaceutical Co., Ltd (Japan)

Key Market Segmentation

Type (Calcium Succinate, Mk-3866, Pacritinib, Sanguinate, Tesidolumab, Others), Product Type (Calcimimetics, Vitamin D, Sterols, Potassium Binders, Calcium-Based Phosphate Binders, Others), Indication (End Stage Renal Disease (ESRD) Induced Hyperparathyroidism, End Stage Renal Disease (ESRD) Induced Hyperphosphatemia, End Stage Renal Disease (ESRD) Induced Hyperkalaemia), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

 

Know More about This Premium Research Report @ https://www.databridgemarketresearch.com/reports/global-end-stage-renal-disease-esrd-drug-market

Browse More Reports:

 

https://www.databridgemarketresearch.com/reports/global-dental-crown-market 

https://www.databridgemarketresearch.com/reports/global-ent-devices-market 

https://www.databridgemarketresearch.com/reports/global-forceps-and-spatulas-market 

https://www.databridgemarketresearch.com/reports/global-gamified-healthcare-solutions-market 

https://www.databridgemarketresearch.com/reports/global-hematology-cbc-analyzers-market 

https://www.databridgemarketresearch.com/reports/global-molecular-modelling-market 

https://www.databridgemarketresearch.com/reports/global-anatomic-pathology-market 

https://www.databridgemarketresearch.com/reports/global-capnography-device-market  

https://www.databridgemarketresearch.com/reports/global-spinal-implants-surgical-devices-market 

About Data Bridge Market Research, Private Ltd

Data Bridge Market Research is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe.

Contact Us

US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – corporatesales@databridgemarketresearch.com